doi: 10.1016/s0014-2999(99)00486-0
Peptides such as BPC-157 (body protection compound 157), LL-37 (antimicrobial peptide LL-37), and KPV (a tripeptide fragment of alpha-MSH: Lys-Pro-Val) are gaining significant attention in functional medicine because of their potent anti-inflammatory properties
The primary endpoint is percent change in body weight from baseline
Research profile Sermorelin is an educational research profile for people comparing mechanism, potential benefits, evidence strength, and related compounds in growth & performance
Currently, CAR-T therapy has demonstrated significant clinical efficacy, and the FDA has approved seven products for the treatment of hematological malignancies: Kymriah, a CD19-specific CAR-T product, was the first to be approved on August 31, 2017, for treating patients with refractory or relapsed B-cell precursor acute lymphoblastic leukemia (B-ALL) (38)